The Latin America, Middle East and Africa Cell Penetrating Peptide Market would witness market growth of 13.3% CAGR during the forecast period (2023-2030).
CPPs play a role in advancing vaccine development and immunotherapy. By enhancing the delivery of antigens or immunomodulatory agents into target cells, CPPs contribute to the development of more effective vaccines and immunotherapeutic approaches. This has implications for infectious diseases, cancer immunotherapy, and personalized medicine. CPPs have become valuable tools for delivering imaging agents into live cells in molecular imaging. This application enables researchers and clinicians to visualize cellular processes, study disease mechanisms, and monitor the efficacy of therapeutic interventions. Integrating CPPs with imaging technologies enhances the precision and sensitivity of molecular imaging approaches.
Additionally, CPPs serve as indispensable research tools in cell biology and molecular biology laboratories. They enable the intracellular delivery of fluorescent probes, small molecules, and biomolecules for studying cellular functions, signal transduction pathways, and protein interactions. The versatility of CPPs enhances the efficiency and scope of various experimental techniques. Likewise, CPPs find applications beyond therapeutics in the cosmetic and dermatological industries. CPPs are incorporated into formulations for skincare products, where they facilitate the delivery of active ingredients into skin cells. This has implications for improving skincare products' efficacy and enhancing their ability to address specific skin concerns.
Growing awareness and demand for healthcare services among the Saudi population can drive the growth of pharmaceutical sector. As people become more health-conscious, there is an increased demand for innovative and effective drugs, including those based on advanced technologies like cell-penetrating peptides. Growing pharmaceutical sector in LAMEA region will boost the demand for cell penetrating peptides in the region.
The Brazil market dominated the LAMEA Cell Penetrating Peptide Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $41.8 Million by 2030. The Argentina market is showcasing a CAGR of 13.9% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 12.9% during (2023 - 2030).
Based on End-use, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organization (CROs), Hospitals & Clinics, and Others. Based on Application, the market is segmented into Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, and Others. Based on Type, the market is segmented into Synthetic CPPs, Protein-derived CPPs, and Chimeric CPPs. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
CPPs play a role in advancing vaccine development and immunotherapy. By enhancing the delivery of antigens or immunomodulatory agents into target cells, CPPs contribute to the development of more effective vaccines and immunotherapeutic approaches. This has implications for infectious diseases, cancer immunotherapy, and personalized medicine. CPPs have become valuable tools for delivering imaging agents into live cells in molecular imaging. This application enables researchers and clinicians to visualize cellular processes, study disease mechanisms, and monitor the efficacy of therapeutic interventions. Integrating CPPs with imaging technologies enhances the precision and sensitivity of molecular imaging approaches.
Additionally, CPPs serve as indispensable research tools in cell biology and molecular biology laboratories. They enable the intracellular delivery of fluorescent probes, small molecules, and biomolecules for studying cellular functions, signal transduction pathways, and protein interactions. The versatility of CPPs enhances the efficiency and scope of various experimental techniques. Likewise, CPPs find applications beyond therapeutics in the cosmetic and dermatological industries. CPPs are incorporated into formulations for skincare products, where they facilitate the delivery of active ingredients into skin cells. This has implications for improving skincare products' efficacy and enhancing their ability to address specific skin concerns.
Growing awareness and demand for healthcare services among the Saudi population can drive the growth of pharmaceutical sector. As people become more health-conscious, there is an increased demand for innovative and effective drugs, including those based on advanced technologies like cell-penetrating peptides. Growing pharmaceutical sector in LAMEA region will boost the demand for cell penetrating peptides in the region.
The Brazil market dominated the LAMEA Cell Penetrating Peptide Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $41.8 Million by 2030. The Argentina market is showcasing a CAGR of 13.9% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 12.9% during (2023 - 2030).
Based on End-use, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organization (CROs), Hospitals & Clinics, and Others. Based on Application, the market is segmented into Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, and Others. Based on Type, the market is segmented into Synthetic CPPs, Protein-derived CPPs, and Chimeric CPPs. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Biosynth Ltd
- Creative Peptides
- Cupid Peptide Company Limited
- Alta Bioscience Ltd
- AnaSpec Inc. (Kaneka Eurogentec S.A.) (Kaneka Corporation)
- Peptomyc SL
- PolyPeptide Group AG
- Bachem Holding AG (Ingro Finanz AG)
- Sarepta Therapeutics, Inc.
- Revance Therapeutics, Inc.
Market Report Segmentation
By End-use- Pharmaceutical and Biotechnology Companies
- Contract Research Organization (CROs)
- Hospitals & Clinics
- Others
- Drug Delivery
- Gene Delivery
- Diagnostics
- Molecular Imaging
- Others
- Synthetic CPPs
- Protein-derived CPPs
- Chimeric CPPs
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Cell Penetrating Peptide Market, by End-use
Chapter 5. LAMEA Cell Penetrating Peptide Market, by Application
Chapter 6. LAMEA Cell Penetrating Peptide Market, by Type
Chapter 7. LAMEA Cell Penetrating Peptide Market, by Country
Chapter 8. Company Profiles
Companies Mentioned
- Biosynth Ltd
- Creative Peptides
- Cupid Peptide Company Limited
- Alta Bioscience Ltd
- AnaSpec Inc. (Kaneka Eurogentec S.A.) (Kaneka Corporation)
- Peptomyc SL
- PolyPeptide Group AG
- Bachem Holding AG (Ingro Finanz AG)
- Sarepta Therapeutics, Inc.
- Revance Therapeutics, Inc.
Methodology
LOADING...
